Isner J M, Kearney M, Bortman S, Passeri J
Department of Medicine (Cardiology), St. Elizabeth's Medical Center, Tufts University School of Medicine, Boston, MA 02135, USA.
Circulation. 1995 Jun 1;91(11):2703-11. doi: 10.1161/01.cir.91.11.2703.
Apoptosis has been recognized in normal, including rapidly proliferating, cell populations and is inferred to be potentially responsible for the maintenance of stable cell numbers in tissues with various degrees of proliferative activity. Previous studies performed in rats indicated that despite the persistence of a relatively high level of injury-induced proliferative activity, total arterial smooth muscle content at 12 weeks remained unchanged from that measured at 2 weeks, suggesting that accrual of vascular smooth muscle cells is mitigated by cell death. The extent to which apoptosis may be observed in human atherosclerosis and/or restenosis, however, has not been previously established.
We performed immunohistochemical studies on 56 specimens retrieved from patients undergoing directional atherectomy for primary atherosclerotic lesions or recurrent arterial narrowing after percutaneous revascularization (restenosis). Immunohistochemical staining disclosed evidence of apoptosis in 35 (63%) of the 56 specimens studied. When present, immunohistochemical evidence of apoptosis was typically limited to < 2% of cells in the specimen. The finding of apoptosis, however, was not distributed equally among four groups of specimens studied. Specimens retrieved from patients with restenosis were more frequently observed to contain foci of apoptosis than specimens retrieved from patients with primary atherosclerotic lesions. Among 14 peripheral arterial specimens from patients with restenosis, 13 (93%) contained foci of apoptosis; in contrast, apoptosis was observed in only 6 (43%) of 14 peripheral specimens from patients with primary lesions (P = .0046). Among coronary arterial specimens, apoptosis was observed in 12 (86%) of 14 specimens from patients with restenosis versus 6 (29%) of 14 specimens from patients with primary obstructions (P < .0075).
Apoptosis is a feature of human vascular pathology, including restenotic lesions and, to a lesser extent, primary atherosclerotic lesions. The findings of the present study suggest that apoptosis may modulate the cellularity of lesions that produce human vascular obstruction, particularly those with evidence of more extensive proliferative activity.
凋亡在正常细胞群体中已被认识到,包括快速增殖的细胞群体,并且据推测其可能负责维持具有不同程度增殖活性的组织中稳定的细胞数量。先前在大鼠中进行的研究表明,尽管损伤诱导的增殖活性持续处于相对较高水平,但12周时动脉平滑肌总量与2周时测量的结果相比没有变化,这表明血管平滑肌细胞的增加因细胞死亡而得到缓解。然而,此前尚未确定在人类动脉粥样硬化和/或再狭窄中可观察到凋亡的程度。
我们对56份标本进行了免疫组织化学研究,这些标本取自因原发性动脉粥样硬化病变或经皮血管再通术后复发性动脉狭窄(再狭窄)而接受定向旋切术的患者。免疫组织化学染色显示,在研究的56份标本中有35份(63%)存在凋亡证据。当存在凋亡时,免疫组织化学证据通常局限于标本中不到2%的细胞。然而,凋亡的发现并非在所研究的四组标本中均匀分布。与取自原发性动脉粥样硬化病变患者的标本相比,取自再狭窄患者的标本更常观察到凋亡灶。在14份来自再狭窄患者的外周动脉标本中,13份(93%)含有凋亡灶;相比之下,在14份来自原发性病变患者的外周标本中,只有6份(43%)观察到凋亡(P = 0.0046)。在冠状动脉标本中,14份来自再狭窄患者的标本中有12份(86%)观察到凋亡,而14份来自原发性梗阻患者的标本中有6份(29%)观察到凋亡(P < 0.0075)。
凋亡是人类血管病理学的一个特征,包括再狭窄病变,在原发性动脉粥样硬化病变中程度较轻。本研究结果表明,凋亡可能调节导致人类血管阻塞的病变的细胞数量,特别是那些具有更广泛增殖活性证据的病变。